TP53 and breast carcinoma: MDA-MB-231 breast cancer cells migrated significantly more quickly through ECM from fibroblasts that had previously been treated with mutp53R273H-exosomes than they did through ECM from untreated fibroblasts or those treated with p53−/−-exosomes (Fig. 6a).